STRATA Skin Sciences, Inc. (SSKN) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SSKN Revenue Growth
Revenue Breakdown (FY 2024)
SSKN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
SSKN Revenue Analysis (2013–2024)
As of May 8, 2026, STRATA Skin Sciences, Inc. (SSKN) generated trailing twelve-month (TTM) revenue of $31.0 million, reflecting significant decline in growth of -21.2% year-over-year. The most recent quarter (Q3 2025) recorded $6.9 million in revenue, down 9.6% sequentially.
Looking at the longer-term picture, SSKN's 5-year compound annual growth rate (CAGR) stands at +1.2%, indicating moderate growth over time. The company achieved its highest annual revenue of $36.2 million in 2022.
Revenue diversification analysis shows SSKN's business is primarily driven by Dermatology Recurring Procedures (63%), and Dermatology Procedures Equipment (37%). With over half of revenue concentrated in Dermatology Recurring Procedures, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including DERM (-27.4% YoY), SKIN (-8.2% YoY), and LNTH (+0.6% YoY), SSKN has underperformed the peer group in terms of revenue growth. Compare SSKN vs DERM →
SSKN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SSKNCurrent | $31M | -21.2% | +1.2% | -27.6% | |
 DERM | $56M | -27.4% | +10.0% | -24.4% | |
 SKIN | $301M | -8.2% | +20.4% | -6.9% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 INMD | $370M | -4.5% | +12.4% | 23.0% | |
 AEYE | $40M | +14.5% | +14.5% | -7.9% |
SSKN Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $33.6M | +0.6% | $19.1M | 56.9% | $-9,255,000 | -27.6% |
| 2023 | $33.4M | -7.8% | $18.5M | 55.3% | $-8,604,000 | -25.8% |
| 2022 | $36.2M | +20.6% | $21.8M | 60.2% | $-4,649,000 | -12.9% |
| 2021 | $30.0M | +29.8% | $19.9M | 66.2% | $-4,402,000 | -14.7% |
| 2020 | $23.1M | -26.9% | $14.1M | 61.2% | $-4,076,000 | -17.7% |
| 2019 | $31.6M | +5.8% | $20.3M | 64.2% | $-3,010,000 | -9.5% |
| 2018 | $29.9M | -5.1% | $17.1M | 57.3% | $-3,355,000 | -11.2% |
| 2017 | $31.4M | -1.0% | $18.0M | 57.1% | $-2,410,000 | -7.7% |
| 2016 | $31.8M | +71.7% | $19.1M | 60.2% | $-3,597,000 | -11.3% |
| 2015 | $18.5M | +1921.3% | $4.8M | 25.8% | $-16,475,000 | -89.1% |
See SSKN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SSKN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SSKN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSSKN — Frequently Asked Questions
Quick answers to the most common questions about buying SSKN stock.
Is SSKN's revenue growth accelerating or slowing?
SSKN revenue declined -21.2% year-over-year, contrasting with the 5-year CAGR of +1.2%. TTM revenue fell to $31M. This reverses the prior growth trend.
What is SSKN's long-term revenue growth rate?
STRATA Skin Sciences, Inc.'s 5-year revenue CAGR of +1.2% reflects the variable expansion pattern. Current YoY growth of -21.2% is below this long-term average.
How is SSKN's revenue distributed by segment?
SSKN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.